Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
THERA-101
- Development stage
- Preclinical
- Lead developer
- Theratome Bio
- Modality
- Recombinant Proteins and Enzymes, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Injectable
01
Overview
THERA-101 is a biologic therapeutic candidate consisting of a concentrated secretome derived from human adipose-derived mesenchymal stromal cells (AD-MSCs). This secretome is a complex cocktail of proteins and microvesicles (exosomes) that possess regenerative and anti-inflammatory properties. Developed by Theratome Bio, THERA-101 is being investigated as a low-volume resuscitation fluid for the treatment of polytrauma, specifically targeting traumatic brain injury (TBI) and hemorrhagic shock. The therapeutic mechanism involves the mitigation of neuroinflammation, reduction of astrocyte activation, and protection of vital organs such as the liver and kidneys from damage following severe trauma. Its low-volume formulation is designed for field-deployable use in austere environments where traditional large-volume fluid resuscitation is impractical.
- Other names
- adipose-derived mesenchymal stromal cell secretomeAD-MSC secretome
02
Targets
IL10 (Interleukin-10)
Beyond the preview
Go deeper on THERA-101.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on THERA-101.